<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01752140</url>
  </required_header>
  <id_info>
    <org_study_id>BPTRVienna</org_study_id>
    <nct_id>NCT01752140</nct_id>
  </id_info>
  <brief_title>A Prospective Randomized Trial of Prostate Biopsy Protocols Comparing the Vienna Nomogram and a Standard 10-core Biopsy Scheme</brief_title>
  <official_title>A Prospective Randomized Trial of Prostate Biopsy Protocols Comparing the Vienna Nomogram and a Standard 10-core Biopsy Scheme</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital de Santa Maria, Portugal</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital de Santa Maria, Portugal</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study, the investigators aim to determine if the Vienna nomogram increases the
      detection rate of TRUS-guided prostate biopsies by conducting a prospective randomized study
      comparing the Vienna nomogram with a 10-core biopsy protocol.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Trans rectal ultrasound (TRUS) guided prostate biopsy remains the standard for prostate
      cancer diagnosis. However, the standard protocols miss 15 to 30% of cancers, leading to a
      variable number of repeat biopsies.

      In 2005 the Vienna nomogram was introduced, defining the number of cores to be obtained in a
      prostate biopsy in relation to age and prostate volume in patients with a serum PSA level of
      2-10 ng/mL.

      The objective of the study is to determine if the Vienna nomogram increases the detection
      rate of trans rectal ultrasound guided prostate biopsies, compared to a 10-core biopsy.

      This prospective randomized study enrolled men eligible for a prostate biopsy were randomized
      to a Vienna nomogram protocol or a 10-core protocol. They were further stratified according
      to age (≤65; &gt;65 and ≤70; &gt;70 years) and prostate volume (≤30; &gt;30 and ≤50; &gt;50 and ≤70; &gt;70
      cc).

      A subgroup analysis for patients with serum PSA values between 2 and 10 ng/mL was performed.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2009</start_date>
  <completion_date type="Actual">July 2010</completion_date>
  <primary_completion_date type="Actual">July 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Prostate cancer detection rate</measure>
    <time_frame>Up to four weeks after intervention</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Prostate cancer detection rate in prostate volume and age subclasses</measure>
    <time_frame>Up to four weeks after intervention</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gleason score concordance between biopsy and prostatectomy specimens</measure>
    <time_frame>Up to four weeks after prostatectomy</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">463</enrollment>
  <condition>Prostate Cancer</condition>
  <arm_group>
    <arm_group_label>10-core prostate biopsy protocol group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ultrasound guided prostate biopsy with extraction of 10 cores</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Vienna nomogram prostate biopsy protocol group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ultrasound guided prostate biopsy performed according to the Vienna nomogram</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>10-core prostate biopsy protocol</intervention_name>
    <description>Local vascular bundle anesthesia with 2% lidocaine was performed using a 22G Chiba needle. Ultrasound guided prostate biopsy using a standard biopsy device to obtain 10 biopsy cores.</description>
    <arm_group_label>10-core prostate biopsy protocol group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Vienna nomogram prostate biopsy protocol</intervention_name>
    <description>Local vascular bundle anesthesia with 2% lidocaine was performed using a 22G Chiba needle. Ultrasound guided prostate biopsy using a standard biopsy device to obtain a number of cores as defined by the Vienna nomogram.</description>
    <arm_group_label>Vienna nomogram prostate biopsy protocol group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  PSA elevation

          -  Abnormal digital rectal examination

          -  Abnormal findings on prostate imaging

        Exclusion Criteria:

          -  Active urinary tract infection

          -  Documented previous pathological prostatitis

          -  History of urinary retention

          -  Recent lower urinary tract surgery
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tito P Leitão, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital de Santa Maria</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Urology Department - Hospital de Santa Maria</name>
      <address>
        <city>Lisboa</city>
        <state>Lisbon</state>
        <zip>1649-035</zip>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Portugal</country>
  </location_countries>
  <reference>
    <citation>Uzzo RG, Wei JT, Waldbaum RS, Perlmutter AP, Byrne JC, Vaughan ED Jr. The influence of prostate size on cancer detection. Urology. 1995 Dec;46(6):831-6.</citation>
    <PMID>7502425</PMID>
  </reference>
  <reference>
    <citation>Djavan B, Margreiter M. Biopsy standards for detection of prostate cancer. World J Urol. 2007 Mar;25(1):11-7. Epub 2007 Mar 7. Review.</citation>
    <PMID>17342490</PMID>
  </reference>
  <reference>
    <citation>Lecuona A, Heyns CF. A prospective, randomized trial comparing the Vienna nomogram to an eight-core prostate biopsy protocol. BJU Int. 2011 Jul;108(2):204-8. doi: 10.1111/j.1464-410X.2010.09887.x. Epub 2010 Nov 19.</citation>
    <PMID>21087452</PMID>
  </reference>
  <reference>
    <citation>Remzi M, Fong YK, Dobrovits M, Anagnostou T, Seitz C, Waldert M, Harik M, Marihart S, Marberger M, Djavan B. The Vienna nomogram: validation of a novel biopsy strategy defining the optimal number of cores based on patient age and total prostate volume. J Urol. 2005 Oct;174(4 Pt 1):1256-60; discussion 1260-1; author reply 1261.</citation>
    <PMID>16145388</PMID>
  </reference>
  <verification_date>December 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 13, 2012</study_first_submitted>
  <study_first_submitted_qc>December 15, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 19, 2012</study_first_posted>
  <last_update_submitted>December 15, 2012</last_update_submitted>
  <last_update_submitted_qc>December 15, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 19, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital de Santa Maria, Portugal</investigator_affiliation>
    <investigator_full_name>Tito Palmela Leitão</investigator_full_name>
    <investigator_title>Dr.</investigator_title>
  </responsible_party>
  <keyword>Prostate cancer</keyword>
  <keyword>Prostate biopsy</keyword>
  <keyword>Vienna nomogram</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prostatic Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

